PSNL earnings date and last-quarter result: last quarter miss, P/E -12.23. Updated 2026-07-23.
Personalis (PSNL) Research Hub
Personalis (PSNL) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 15.88 USD (+0.19%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -12.23, market cap 1.16B. This hub links to the full technical, earnings and options research available for PSNL.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 15.88 USD (+0.19%) |
| 52-week range | 9.52 USD – 18.89 USD |
| Trend regime | Range |
| 14-day RSI | 43.9 (Bearish) |
| Trailing P/E | -12.23 |
| Market cap | 1.16B |
| Dividend yield | 0.00% |
Available research for PSNL
Covered Call on PSNL: how it works, illustrative setup around the real 15.88 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PSNL: how it works, illustrative setup around the real 15.88 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PSNL: how it works, illustrative setup around the real 15.88 USD price, max profit/loss, breakeven and when to use it. Educational.
PSNL technical analysis: range, last 15.88 USD, RSI 43.9, 52w range 9.52 USD–18.89 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PSNL in?
Personalis (PSNL) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is PSNL in an uptrend or downtrend?
As of 2026-10-26, PSNL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PSNL's trailing P/E ratio?
PSNL's trailing P/E is -12.23, with a market cap of 1.16B. See the earnings research page for full valuation detail.